February 17, 2023
February 17, 2023 - Travere Therapeutics, Inc. has announced that the U.S. Food and Drug Administration has granted accelerated approval to FilspariTM
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health
February 17, 2023
February 17, 2023 – Apellis Pharmaceuticals, Inc. a global biopharmaceutical company and leader in complement, has announced that FDA has approved SyfovreTM
February 16, 2023
February 16, 2023 - Chiesi Global Rare Diseases, (a business unit of Chiesi Farmaceutici S.p.A., an
international research-focused healthcare Group, Chiesi Group)
February 3, 2023
February 3, 2023 - The Food and Drug Administration has approved sacituzumab govitecan-hziy
February 2, 2023
February 02, 2023 - Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops
February 1, 2023
February 1, 2023 - The FDA has recognized it needs to make its vaccination messaging simple and clear moving forward.
The COVID-19 pandemic has plagued America for nearly three years but the end might be in sight.
February 1, 2023
February 1, 2023 - The U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as
the first oral treatment for anemia (decreased number of red
January 31, 2023
January 31, 2023 - FDA published draft guidance for industry, “M13A Bioequivalence for Immediate-
Release Solid Oral Dosage Forms